TY - JOUR
KW - Abuse-Deterrent Formulations/methods
KW - adverse effects
KW - Analgesics, Opioid/administration & dosage/chemistry
KW - Animals
KW - Cross-Over Studies
KW - Dosage
KW - Drug Interactions
KW - Efficacy
KW - Humans
KW - Opiate Substitution Treatment/methods
KW - opioid dependence
KW - Opioid-Related Disorders/drug therapy/metabolism/psychology
KW - Opioids
KW - Oxaydo
KW - Oxycodone
KW - Oxycodone/administration & dosage/chemistry
KW - pain
KW - Percocet
KW - Pregnancy
KW - Roxicodone
KW - Roxybond
KW - Safety
BT - The Medical letter on drugs and therapeutics
C5 - Opioids & Substance Use
CP - 1555
CY - United States
IS - 1555
JF - The Medical letter on drugs and therapeutics
PP - United States
PY - 2018
SN - 1523-2859; 0025-732X
SP - 145
EP - 146
EP - 
T1 - Roxybond--an abuse-deterrent formulation of short-acting oxycodone
T2 - The Medical letter on drugs and therapeutics
TI - Roxybond--an abuse-deterrent formulation of short-acting oxycodone
U1 - Opioids & Substance Use
U2 - 30383730
VL - 60
VO - 1523-2859; 0025-732X
Y1 - 2018
ER -